These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 24117503)

  • 1. Optimising delivery of care in coeliac disease - comparison of the benefits of repeat biopsy and serological follow-up.
    Sharkey LM; Corbett G; Currie E; Lee J; Sweeney N; Woodward JM
    Aliment Pharmacol Ther; 2013 Nov; 38(10):1278-91. PubMed ID: 24117503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IgA-class transglutaminase antibodies in evaluating the efficacy of gluten-free diet in coeliac disease.
    Kaukinen K; Sulkanen S; Mäki M; Collin P
    Eur J Gastroenterol Hepatol; 2002 Mar; 14(3):311-5. PubMed ID: 11953698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Value of IgA tTG in Predicting Mucosal Recovery in Children With Celiac Disease on a Gluten-Free Diet.
    Leonard MM; Weir DC; DeGroote M; Mitchell PD; Singh P; Silvester JA; Leichtner AM; Fasano A
    J Pediatr Gastroenterol Nutr; 2017 Feb; 64(2):286-291. PubMed ID: 28112686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gluten-dependent small bowel mucosal transglutaminase 2-specific IgA deposits in overt and mild enteropathy coeliac disease.
    Koskinen O; Collin P; Korponay-Szabo I; Salmi T; Iltanen S; Haimila K; Partanen J; Mäki M; Kaukinen K
    J Pediatr Gastroenterol Nutr; 2008 Oct; 47(4):436-42. PubMed ID: 18852635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tests for Serum Transglutaminase and Endomysial Antibodies Do Not Detect Most Patients With Celiac Disease and Persistent Villous Atrophy on Gluten-free Diets: a Meta-analysis.
    Silvester JA; Kurada S; Szwajcer A; Kelly CP; Leffler DA; Duerksen DR
    Gastroenterology; 2017 Sep; 153(3):689-701.e1. PubMed ID: 28545781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can celiac serology alone be used as a marker of duodenal mucosal recovery in children with celiac disease on a gluten-free diet?
    Bannister EG; Cameron DJ; Ng J; Chow CW; Oliver MR; Alex G; Catto-Smith AG; Heine RG; Webb A; McGrath K; Simpson D; Hardikar W
    Am J Gastroenterol; 2014 Sep; 109(9):1478-83. PubMed ID: 25070050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of gluten immunogenic peptides in the urine of patients with coeliac disease reveals transgressions in the gluten-free diet and incomplete mucosal healing.
    Moreno ML; Cebolla Á; Muñoz-Suano A; Carrillo-Carrion C; Comino I; Pizarro Á; León F; Rodríguez-Herrera A; Sousa C
    Gut; 2017 Feb; 66(2):250-257. PubMed ID: 26608460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Small-bowel mucosal transglutaminase 2-specific IgA deposits in coeliac disease without villous atrophy: a prospective and randomized clinical study.
    Kaukinen K; Peräaho M; Collin P; Partanen J; Woolley N; Kaartinen T; Nuutinen T; Halttunen T; Mäki M; Korponay-Szabo I
    Scand J Gastroenterol; 2005 May; 40(5):564-72. PubMed ID: 16036509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coeliac disease and the liver: spectrum of liver histology, serology and treatment response at a tertiary referral centre.
    Majumdar K; Sakhuja P; Puri AS; Gaur K; Haider A; Gondal R
    J Clin Pathol; 2018 May; 71(5):412-419. PubMed ID: 28970297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum I-FABP as marker for enterocyte damage in coeliac disease and its relation to villous atrophy and circulating autoantibodies.
    Adriaanse MP; Tack GJ; Passos VL; Damoiseaux JG; Schreurs MW; van Wijck K; Riedl RG; Masclee AA; Buurman WA; Mulder CJ; Vreugdenhil AC
    Aliment Pharmacol Ther; 2013 Feb; 37(4):482-90. PubMed ID: 23289539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Role of an IgA/IgG-Deamidated Gliadin Peptide Point-of-Care Test in Predicting Persistent Villous Atrophy in Patients With Celiac Disease on a Gluten-Free Diet.
    Lau MS; Mooney PD; White WL; Rees MA; Wong SH; Kurien M; Trott N; Leffler DA; Hadjivassiliou M; Sanders DS
    Am J Gastroenterol; 2017 Dec; 112(12):1859-1867. PubMed ID: 29016564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High tissue-transglutaminase antibody level predicts small intestinal villous atrophy in adult patients at high risk of celiac disease.
    Zanini B; Magni A; Caselani F; Lanzarotto F; Carabellese N; Villanacci V; Ricci C; Lanzini A
    Dig Liver Dis; 2012 Apr; 44(4):280-5. PubMed ID: 22119616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mucosal healing and mortality in coeliac disease.
    Lebwohl B; Granath F; Ekbom A; Montgomery SM; Murray JA; Rubio-Tapia A; Green PH; Ludvigsson JF
    Aliment Pharmacol Ther; 2013 Feb; 37(3):332-9. PubMed ID: 23190299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Persistent mucosal abnormalities in coeliac disease are not related to the ingestion of trace amounts of gluten.
    Selby WS; Painter D; Collins A; Faulkner-Hogg KB; Loblay RH
    Scand J Gastroenterol; 1999 Sep; 34(9):909-14. PubMed ID: 10522611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Titers of anti-tissue transglutaminase antibody correlate well with severity of villous abnormalities in celiac disease.
    Singh P; Kurray L; Agnihotri A; Das P; Verma AK; Sreenivas V; Dattagupta S; Makharia GK
    J Clin Gastroenterol; 2015 Mar; 49(3):212-7. PubMed ID: 24583754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short article: Mortality and differential diagnoses of villous atrophy without coeliac antibodies.
    Schiepatti A; Biagi F; Fraternale G; Vattiato C; Balduzzi D; Agazzi S; Alpini C; Klersy C; Corazza GR
    Eur J Gastroenterol Hepatol; 2017 May; 29(5):572-576. PubMed ID: 28350748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential celiac children: 9-year follow-up on a gluten-containing diet.
    Auricchio R; Tosco A; Piccolo E; Galatola M; Izzo V; Maglio M; Paparo F; Troncone R; Greco L
    Am J Gastroenterol; 2014 Jun; 109(6):913-21. PubMed ID: 24777149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes of Seropositive Patients With Marsh 1 Histology in Clinical Practice.
    Singh P; Lauwers GY; Garber JJ
    J Clin Gastroenterol; 2016 Sep; 50(8):619-23. PubMed ID: 27003856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered small-bowel mucosal vascular network in untreated coeliac disease.
    Myrsky E; Syrjänen M; Korponay-Szabo IR; Mäki M; Kaukinen K; Lindfors K
    Scand J Gastroenterol; 2009; 44(2):162-7. PubMed ID: 18985542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disappearance of endomysial antibodies in treated celiac disease does not indicate histological recovery.
    Dickey W; Hughes DF; McMillan SA
    Am J Gastroenterol; 2000 Mar; 95(3):712-4. PubMed ID: 10710062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.